RTW Investments’s Abeona Therapeutics ABEO Stock Holding History

RTW Investments’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-776	Closed	-$116K	–	33
2016 Q3	$116K	Buy	+776	New	+$75.9K	0.04%	36

Other funds holding ABEO

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

RTW Investments's ABEO Position: Q4 2016 in Review

RTW Investments sold out of Abeona Therapeutics (ABEO) in Q4 2016, closing a stake of 776 shares — an estimated $116K sold.

RTW Investments first reported a position in ABEO in Q3 2016 and held it in 1 quarter. The position peaked at $116K in Q3 2016. 54 funds tracked by Wall St. Rank hold ABEO as of Q4 2016.

RTW Investments reported no remaining Abeona Therapeutics position as of Q4 2016 after selling out during the quarter.
RTW Investments sold 776 Abeona Therapeutics shares in Q4 2016, an estimated $116K.
RTW Investments first reported a position in Abeona Therapeutics in Q3 2016 and held it in 1 quarter.
RTW Investments's Abeona Therapeutics position peaked at $116K in Q3 2016.
54 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2016.

Based on RTW Investments's 13F filing for Q4 2016, filed 15 Feb 2017.